Researchers in Liverpool and Oxford have found that surgery for a common elbow fracture in children offers no clinical ...
Five-Year Survival Outcomes With Atezolizumab After Chemotherapy in Resected Stage IB-IIIA Non–Small Cell Lung Cancer (IMpower010): An Open-Label, Randomized, Phase III Trial In this global phase III ...
A tailored approach of vitamin D3 supplementation in patients who have suffered a heart attack significantly reduces their risk of a second heart attack, a new ...
Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, today announced positive topline results from its randomized, ...
An interactive smart speaker intervention reduced mental distress and improved diabetes-related outcomes in older adults with type 2 diabetes. Participants using the virtual assistant showed ...